What is Arintra?
Founded in 2020 by Nitesh Shroff and Preeti Bhargava, Arintra operates at the intersection of artificial intelligence and healthcare administration. The company provides a sophisticated GenAI-native platform designed to automate the complex translation of clinical documentation into accurate insurance codes. By integrating clinical documentation improvement (CDI) and denials prevention into a unified workflow, Arintra addresses critical inefficiencies in hospital billing and revenue cycle management. The platform serves as a vital tool for healthcare providers, enabling them to reduce administrative burdens while ensuring precision in medical coding and compliance.
The company's market position is bolstered by its ability to bridge the gap between clinical care and financial operations. By leveraging advanced generative models, Arintra enables health systems to optimize their revenue cycles, effectively minimizing the risk of claim denials and improving overall financial health for large-scale medical organizations.
How much funding has Arintra raised?
Arintra has raised a total of $46M across 2 funding rounds:
Series A
$21M
Series B
$25M
Series A (2025): $21M with participation from Peak XV Partners, Spider Capital, Endeavor Health, and Y Combinator
Series B (2026): $25M led by Counterpart, Endeavor Health, Ten13 Management, Yale New Haven Health, Y Combinator, Peak XV Partners, and Spider Capital Partners Management
Key Investors in Arintra
Peak XV Partners
A prominent venture capital firm specializing in early-stage and growth-stage technology investments across Asia, providing strategic guidance and operational expertise to transformative startups.
Endeavor Health
A large, not-for-profit integrated healthcare system that provides coordinated medical services and serves as a strategic partner for healthcare innovation.
Y Combinator
A premier startup accelerator and seed-stage investor known for fostering high-growth technology companies through mentorship and capital support.
What's next for Arintra?
With this latest infusion of capital, Arintra is well-positioned to scale its autonomous coding infrastructure and expand its footprint across major health systems. The strategic focus will likely center on deepening the platform's integration capabilities and enhancing its predictive analytics for denials prevention. As the healthcare industry continues to prioritize digital transformation, Arintra's ability to provide a seamless, AI-driven solution for revenue cycle management will be pivotal in maintaining its competitive edge. The company is expected to leverage its network of institutional backers to accelerate product adoption and further refine its proprietary AI models to meet the evolving demands of complex clinical environments.
See full Arintra company page
